Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control

Annals of Internal Medicine

Volumn 124, Issue 3, 1996, Pages 329-334

  Edmond, Michael B ^a   Wenzel, Richard P ^a   Pasculle, A William ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; DISEASE TRANSMISSION; HEALTH CARE PERSONNEL; HUMAN; INFECTION CONTROL; INTRANASAL DRUG ADMINISTRATION; LABORATORY INFECTION; NOSE SMEAR; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0030043013     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-3-199602010-00008     Document Type: Review

References (53)

1. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci N Engl J Med. 1987;316:927-31
2. Veach LA, Pfaller MA, Barrett M, Koontz FP, Wenzel RP. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and blood-stream infection. J Clin Microbiol 1990,28 2064-8
3. Nosocomial 'enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993;42 597-9.
4. Edmond MB, Ober JF, Weinbaum DL, Pfaller MA, Hwang T, Sanford MD, et al. Vancomycin-resistant Enterococcus faecium bacteremia risk factors for infection Clin Infect Dis 1996;20:1126-33.
5. Noble WC, Virani Z, Cree RG. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus FEMS Microbiol Lett. 1992;72 195-8.
6. Fekety FR Jr. The epidemiology and prevention of staphylococcal infection Medicine 1964,45 593-613.
7. Casewell MW, Hill RL. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1986;18(Suppl A).1-12
8. Reagan DR, Doebbeling BN, Pfaller MA, Sheetz CT, Houston AK, Hollis RJ, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment Ann Intern Med 1991;114:101-6
9. Haley RW, Hightower AW, Khabbaz RF, Thornsberry C Martone WJ, Allen JR, et al. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med 1982,97 297-308.
10. Cohen SH. Morita MM, Bradford M. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med. 1991,91(Suppl 3B):233S-7S.
11. Locksley RM, Cohen ML, Quinn TC, Tompkins LS, Coyle MB, Kirihara JM, et al. Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection Ann Intern Med. 1982; 97 317-24
12. Peacock JE Jr, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus introduction and spread within a hospital Ann Intern Med 1980,93: 526-32.
13. Tuazon CU. Perez A, Kishaba T, Sheagren JN. Staphylococcus aureus among insulin-injecting diabetic patients An increased carriage rate. JAMA. 1975,231.1272.
14. Kirmani N, Tuazon CU, Murray HW, Parrish AE, Sheagren JN. Staphylococcus aureus carriage rate of patients receiving long-term hemodialysis Arch Intern Med. 1978,138 1657-9
15. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcal aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD) Pent Dial Int. 1989,9. 61-4
16. Tuazon CU, Sheagren JN. Increased rate of carriage of Staphylococcus aureus among narcotic addicts. J Infect Dis 1974,129 725-7
17. Ganesh R, Castle D. McGibbon D, Phillips I, Bradbeer C Staphylococcal carriage and HIV infection [Letter]. Lancet 1989;2 558
18. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992,11 985-9
19. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD. Hanchett J. et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis Efficacy of antibiotic prophylaxis N Engl J Med. 1986;315:91-6
20. Tulloch LG. Nasal carriage in staphylococcal skin infections. Br Med J. 1954, 2 912-3.
21. Sesso R, Draibe S, Castelo A, Sato I, Lerne I, Barbosa D, et al. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol. 1989,31 264-8
22. Calia FM, Wolinsky E, Mortimer EA Jr, Abrams JS, Rammelkamp CH Jr. Importance of the carrier state as a source of Staphylococcus aureus in wound sepsis J Hyg 1969,67:49-57
23. Doebbeling BN, Breneman DL, Neu HC, Aly R, Yangco BG, Holley HP Jr, et al. Elimination of Staphylococcus aureus nasal carriage in health care workers, analysis of six clinical trials with calcium mupirocin ointment Clin Infect Dis. 1993,17 466-74
24. Boelaert JR, Van Landuyt HW, Godard CA, Daneels RF, Schurgers ML, Matthys EG, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients Nephrol Dial Transplant. 1993,8 235-9.
25. Williams RE. Epidemiology of airborne staphylococcal infection. Bacteriol Rev 1966;30:660-74
26. Tanner EI, Bullin J, Bullin CH, Gamble DR. An outbreak of post-operative sepsis due to a staphylococcal disperser J Hyg 1980;85:219-25
27. Ayliffe GA, Babb JR, Collings BJ. Dispersal of Staphylococcus aureus [Letter]. Lancet 1974 2 1573
28. White A. Relation between quantitative nasal cultures and dissemination of staphylococci J Lab Clin Med. 1961,58 273-7.
29. Hambraeus A. Studies on transmission of Staphylococcue aureus in an isolated ward for burned patients J Hyg 1973,71 171-83
30. Ransjö U. Isolation care of infection-prone burn patients Scand J Infect Dis. 1978 11:1-46
31. Lowbury EJ, Lilly HA, Bull JP. Disinfection of hands removal of transient organisms Br Med J. 1964;2:230-3
32. Lilly HA, Lowbury EJ. Transient skin flora their removal by cleansing or disinfection in relation to their mode of deposition. J Clin Pathol. 1978,31: 919-22.
33. Ayliffe GA, Babb JR, Quoraishi AH. A test for 'hygienic' hand disinfection J Clin Pathol 1978,31:923-8.
34. Ojajärvi J. Effectiveness of hand washing and disinfection methods in removing transient bacteria after patient nursing. J Hyg 1980,85.193-203.
35. Kjølen H, Andersen BM. Handwashing and disinfection of heavily contaminated hands - effective or ineffective? J Hosp Infect 1992,21.61-71.
36. Wade JJ, Casewell MW. The evaluation of residual antimicrobial activity on hands and its clinical relevance J Hosp Infect. 1991;18(Suppl B):23-8
37. Wade JJ, Desal N, Casewell MW. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae. J Hosp Infect 1991;18:211-8.
38. Doebbeling BN, Stanley GL, Sheetz CT, Pfaller MA, Houston AK, Annis L, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units N Engl J Med. 1992,327 88-93.
39. Haley RW, Cushion NB, Tenover FC, Bannerman TL, Dryer D, Ross J, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit J Infect Dis 1995;171:614-24.
40. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994,19:1123-8
41. Doebbeling BN. Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphytococcus aureus carriage Arch Intern Med. 1994,154: 1505-8.
42. Rahman M, Noble WC, Cookson B. Mupirocin-resistant Staphylococcus aureus Lancet. 1987;2 387.
43. Smith GE, Kennedy CT. Staphylococcus aureus resistant to mupirocin [Letter]. J Antimicrob Chemother. 1988,21:141-2
44. Cookson BD, Lacey RW, Noble WC, Reeves DS, Wise R, Redhead RJ. Mupirocin-resistant Staphylococcus aureus [Letter]. Lancet. 1990,335.1095-6.
45. Baird D, Coia J. Mupirocin-resistant Staphylococcus aureus Lancet 1987;2. 387-8.
46. Cookson BD. Mupirocin resistance in staphylococci. J Antimicrob Chemother 1990;25 497-501
47. Gilbart J, Perry CR, Slocombe B. High-level mupirocin resistance in Staphylococcus aureus evidence for two distinct isoleucyl-tRNA synthetases Antimicrob Agents Chemother. 1993,37.32-8
48. Layton MC, Perez M, Heald P, Patterson JE. An outbreak of mupirocinresistant Staphylococcus aureus on a dermatology ward associated with an environmental reservoir. Infect Control Hosp Epidemiol 1993,14:369-75
49. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC) Infect Control Hosp Epidemiol 1995;16:105-13
50. Watanakunakorn C, Brandt J, Durkin P, Santore S, Bota B, Stahl CJ. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am J Infect Control 1992,20 138-41.
51. Muro K, Lim PB. A comparison of mupirocin and rifampicin in short term eradication of Staphylococcus aureus nasal carriage in hemodialysis patients J Am Soc Nephrol 1991,2 340.
52. Casewell MW, Hill RL. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid') - a controlled trial. J Antimicrob Chemother 1986,17 365-72
53. National Committee for Clinical Laboratory Standards. Protection of Laboratory Workers from Infectious Disease Transmitted by Blood, Body Fluid, and Tissue. Villanova, PA National Committee for Clinical Laboratory Standards; 1991:31-2.